Chain Reaction Ltd. Revenue and Competitors

Israel, ISR

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Chain Reaction Ltd.'s estimated annual revenue is currently $26.9M per year.(i)
  • Chain Reaction Ltd.'s estimated revenue per employee is $296,154

Employee Data

  • Chain Reaction Ltd. has 91 Employees.(i)
  • Chain Reaction Ltd. grew their employee count by -14% last year.

Chain Reaction Ltd.'s People

NameTitleEmail/Phone
1
Co-founder, CEOReveal Email/Phone
2
Chief Revenue Officer, GM US & Taiwan OperationsReveal Email/Phone
3
VP Account ManagementReveal Email/Phone
4
Senior Director VLSI DigitalReveal Email/Phone
5
Field Application ManagerReveal Email/Phone
6
EngineerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$36.9M134-8%$105MN/A
#2
$46M1528%N/AN/A
#3
$1.7M10-9%N/AN/A
#4
$27M91-14%N/AN/A
#5
$8.8M3732%N/AN/A
#6
$9M3836%N/AN/A
#7
$13.1M49-40%N/AN/A
#8
$27M91-14%N/AN/A
#9
$43.6M13319%N/AN/A
#10
$44.2M1461%N/AN/A
Add Company

What Is Chain Reaction Ltd.?

Chain Reaction is a semiconductor company focused on accelerating blockchain and privacy preserving technologies. Founded in 2019, Chain Reaction has an expanding team of 30+ employees across offices in Israel, US and Taiwan.

keywords:N/A

N/A

Total Funding

91

Number of Employees

$26.9M

Revenue (est)

-14%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Chain Reaction Ltd. News

2022-04-20 - Recent real-time polymerase chain reaction (PCR) Market ...

The real-time polymerase chain reaction (PCR) market is expected to ... F. Hoffmann-La Roche Ltd, Fluidigm Corporation, Lumex Instruments,...

2022-04-20 - Infectious Disease Diagnostics Market Size Worth $37.94Bn, Globally, by 2028 at 6.8% CAGR - Exclusive Report by The Insight Partners

... Technology (Immunodiagnostics, Polymerase Chain Reaction, Next Generation ... In May 2022, F. HOFFMANN-LA ROCHE LTD. entered into a...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$27M91-14%N/A
#2
$19.5M12233%N/A